OTC Markets OTCPK - Delayed Quote USD

Corix Bioscience, Inc. (CXBS)

Compare
0.0000 -0.0001 (-99.00%)
At close: January 8 at 3:43 PM EST
Loading Chart for CXBS
DELL
  • Previous Close 0.0001
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.2500
  • Volume 4,059
  • Avg. Volume 4,059
  • Market Cap (intraday) 20
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Corix Bioscience, Inc. provides cannabidiol (CBD) oil for various medicinal purposes. It engages in the planting, harvesting, and extraction of CBD oil from the industrial Hemp plant. The company was formerly known as American Housing Income Trust, Inc. and changed its name to Corix Bioscience, Inc. in June 2017. Corix Bioscience, Inc. Corix Bioscience, Inc. is headquartered in Phoenix, Arizona.

www.corixbioscience.com

Recent News: CXBS

Performance Overview: CXBS

Trailing total returns as of 6/22/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CXBS
0.00%
MSCI WORLD
10.68%

1-Year Return

CXBS
0.00%
MSCI WORLD
19.81%

3-Year Return

CXBS
0.00%
MSCI WORLD
17.63%

5-Year Return

CXBS
100.00%
MSCI WORLD
61.04%

Compare To: CXBS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CXBS

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    360.87k

  • Total Debt/Equity (mrq)

    1.41%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: CXBS

Company Insights: CXBS

Research Reports: CXBS